Globus Medical Inc to buy US-based Nevro Corp for $250 million all cash
Globus Medical, a US-based medical device company, will buy Nevro Corp. for $250 million in an all-cash deal.
Globus Medical, a US-based medical device company, will buy Nevro Corp. for $250 million in an all-cash deal.
United Therapeutics Corporation, a public benefit corporation, got approval from US regulators to start a clinical trial for organ transplantation from genetically modified
HQ TeamĀ February 6, 2025: A phase I clinical trial has shown that personalized cancer vaccines targeting driver mutations can lead to 100%
HQ Team February 6, 2025: The U.S. Food and Drug Administration (FDA) issued a critical Class I recallāthe most severe categoryāfor Medtronicās Becker
Bharti Jayshankar February 5, 2025: Depression, a mental health condition affecting over 280 million people worldwide, is often accompanied by significant changes in
Supernus Pharmaceuticals Incās injection for treating people with advanced Parkinsonās disease got a green light from the US regulator after two earlier rejections.
All the US Agency for International Development (USAID) direct hire personnel have been placed on administrative leave globally.
The worldās first-ever clinical efficacy trial of a vaccine for Ebola disease arising out of the Sudan virus has started in Uganda, the
Bharti Jayshankar February 4, 2025: Climate change has emerged as a significant factor influencing weather patterns across the globe, particularly in arid regions